APPBP2
Amyloid protein-binding protein 2
Also known as: APBP2_HUMAN, Hs.84084, KIAA0228, PAT1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92624
- Gene
- APPBP2
- Ensembl
- ENSG00000062725
- Chromosome
- 17
- Canonical length
- 585 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene interacts with microtubules and is functionally associated with beta-amyloid precursor protein transport and/or processing. The beta-amyloid precursor protein is a cell surface protein with signal-transducing properties, and it is thought to play a role in the pathogenesis of Alzheimer's disease. The encoded protein may be involved in regulating cell death. This gene has been found to be highly expressed in breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
585 residues, UniProt reviewed canonical sequence.
>Q92624|APPBP2
1 MAAVELEWIP ETLYNTAISA VVDNYIRSRR DIRSLPENIQ FDVYYKLYQQ GRLCQLGSEF
61 CELEVFAKVL RALDKRHLLH HCFQALMDHG VKVASVLAYS FSRRCSYIAE SDAAVKEKAI
121 QVGFVLGGFL SDAGWYSDAE KVFLSCLQLC TLHDEMLHWF RAVECCVRLL HVRNGNCKYH
181 LGEETFKLAQ TYMDKLSKHG QQANKAALYG ELCALLFAKS HYDEAYKWCI EAMKEITAGL
241 PVKVVVDVLR QASKACVVKR EFKKAEQLIK HAVYLARDHF GSKHPKYSDT LLDYGFYLLN
301 VDNICQSVAI YQAALDIRQS VFGGKNIHVA TAHEDLAYSS YVHQYSSGKF DNALFHAERA
361 IGIITHILPE DHLLLASSKR VKALILEEIA IDCHNKETEQ RLLQEAHDLH LSSLQLAKKA
421 FGEFNVQTAK HYGNLGRLYQ SMRKFKEAEE MHIKAIQIKE QLLGQEDYEV ALSVGHLASL
481 YNYDMNQYEN AEKLYLRSIA IGKKLFGEGY SGLEYDYRGL IKLYNSIGNY EKVFEYHNVL
541 SNWNRLRDRQ YSVTDALEDV STSPQSTEEV VQSFLISQNV EGPSCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against APPBP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- testis: 22 nTPM
- cerebral cortex: 18 nTPM
- ovary: 18 nTPM
- retina: 16 nTPM
- cerebellum: 15 nTPM
- adipose tissue: 14 nTPM
Single-cell type
- early spermatids: 504 nCPM
- sertoli cells: 327 nCPM
- podocytes: 327 nCPM
- late primary spermatocytes: 220 nCPM
- oligodendrocytes: 198 nCPM
- adipocytes: 190 nCPM
Immune cell
- basophil: 14 nTPM
- NK-cell: 13 nTPM
- non-classical monocyte: 12 nTPM
- eosinophil: 12 nTPM
- neutrophil: 12 nTPM
- naive CD4 T-cell: 12 nTPM
Brain region
- white matter: 44 nTPM
- cerebral cortex: 35 nTPM
- basal ganglia: 31 nTPM
- cerebellum: 31 nTPM
- spinal cord: 31 nTPM
- thalamus: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.09
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular protein transport
- intracellular transport
- negative regulation of beige fat cell differentiation
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein ubiquitination
- ubiquitin-dependent protein catabolic process via the C-end degron rule pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tetratricopeptide-like helical domain superfamily
- Tetratricopeptide repeat
- Tetratricopeptide repeat
- Amyloid protein-binding protein 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of APPBP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads APPBP2 as an antibody target. Whether an autoantibody or antibody against APPBP2 could matter depends on whether native APPBP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
APPBP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label APPBP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...